AR068988A1 - Composiciones farmaceuticas - Google Patents
Composiciones farmaceuticasInfo
- Publication number
- AR068988A1 AR068988A1 ARP080104473A ARP080104473A AR068988A1 AR 068988 A1 AR068988 A1 AR 068988A1 AR P080104473 A ARP080104473 A AR P080104473A AR P080104473 A ARP080104473 A AR P080104473A AR 068988 A1 AR068988 A1 AR 068988A1
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- aqueous pharmaceutical
- pharmaceutical composition
- oxy
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente proporciona composiciones acuosas farmacéuticas que comprenden un compuesto que es 4-[(4-clorofenil)metil]-2-({(2R)-1-[4-(4-{[3-(hexahidro-1H-azepin-1-il)propil]oxi}fenil)butil]-2-pirrolidinil}metil)-1(2H)-ftalazinona, de fórmula (1), o una sal suya farmacéuticamente aceptable, y su uso en el tratamiento de diversas enfermedades inflamatorias y/o alérgicas tales como rinitis alérgica. Reivindicación 2: Una composición farmacéutica acuosa que comprende (i) un compuesto que es 4-[(4-clorofenil)metil]-2-({(2R)-1-[4-(4-{[3-(hexahidro-1H-azepin-1-il)propil]oxi}fenil)butil]-2-pirrolidinil}metil)-1(2H)-ftalazinona, de fórmula (1), o una sal del mismo farmacéuticamente aceptable; y (ii) un compuesto que es éster S-fluorometílico de ácido 6a,9a-difluoro-17a-[(2-furanilcarbonil)oxi]-11b-hidroxi-16a-metil-3-oxo-androsta-1,4-dien-17b-carbotioico (furoato de fluticasona), de fórmula (2), o un solvato suyo. Reivindicación 7: Una composición farmacéutica acuosa de acuerdo con una cualquiera de las reivindicaciones 1 a 6, que comprende además: a) un agente suspensor; b) un agente de conservación; c) un agente humectante; y d) un agente regulador de la isotonicidad. Reivindicación 8: Una composición farmacéutica acuosa de acuerdo con la reivindicación 7, que comprende además un co-disolvente. Reivindicación 29: Una composición farmacéutica acuosa de acuerdo con una cualquiera de las reivindicaciones 1 a 28, que comprende la sal 1,5-naftalenodisulfonato de 4-[(4-clorofenil)metil]-2-({(2R)-1-[4-(4-{[3-(hexahidro-1H-azepin-1-il)propil]oxi}fenil)butil]-2-pirrolidinil}metil)-1(2H)-ftalazinona, monohidrato. Reivindicación 30: Una composición farmacéutica acuosa de acuerdo con una cualquiera de las reivindicaciones 2 a 28, que comprende furoato de fluticasona en forma no solvatada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98022607P | 2007-10-16 | 2007-10-16 | |
US5723008P | 2008-05-30 | 2008-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR068988A1 true AR068988A1 (es) | 2009-12-23 |
Family
ID=40198721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080104473A AR068988A1 (es) | 2007-10-16 | 2008-10-14 | Composiciones farmaceuticas |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR068988A1 (es) |
CL (1) | CL2008003036A1 (es) |
PE (1) | PE20091089A1 (es) |
TW (1) | TW200932243A (es) |
UY (1) | UY31400A1 (es) |
WO (1) | WO2009050159A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0811447D0 (en) * | 2008-06-20 | 2008-07-30 | Glaxo Group Ltd | Formulations |
CN104869980A (zh) * | 2012-12-17 | 2015-08-26 | 葛兰素集团有限公司 | 用于治疗炎症性病症和/或变应性病症的左卡巴斯汀和糠酸氟替卡松的组合 |
WO2022113008A1 (en) | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
MX2008013406A (es) * | 2006-04-20 | 2008-11-04 | Glaxo Group Ltd | Derivados de 4-bencilftalazinona 2-sustituida como antagonistas de la histamina h1 y h3. |
-
2008
- 2008-10-14 AR ARP080104473A patent/AR068988A1/es not_active Application Discontinuation
- 2008-10-14 TW TW097139419A patent/TW200932243A/zh unknown
- 2008-10-14 WO PCT/EP2008/063781 patent/WO2009050159A1/en active Application Filing
- 2008-10-14 CL CL2008003036A patent/CL2008003036A1/es unknown
- 2008-10-14 PE PE2008001765A patent/PE20091089A1/es not_active Application Discontinuation
- 2008-10-16 UY UY31400A patent/UY31400A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009050159A1 (en) | 2009-04-23 |
PE20091089A1 (es) | 2009-08-24 |
CL2008003036A1 (es) | 2009-05-08 |
TW200932243A (en) | 2009-08-01 |
UY31400A1 (es) | 2009-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901514A1 (ru) | Новая сольватная и кристаллическая форма производных карбамоилциклогексана | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
UY29840A1 (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
LTC1755590I2 (lt) | Glikopirolato ir beta2 adrenoceptoriaus agonisto derinys | |
CR9003A (es) | 2,6 sustituido-4-monosustituido amino-pirimidinas como antagonistas del repector de prostaglandina d2 | |
CR8918A (es) | Derivados de triazolopiridinilsulfanilo como inhibidores de quinasa map p38 | |
AR061134A1 (es) | Derivados de tioxantina | |
PE20091386A1 (es) | Piperidino-dihidrotienopirimidinas sustituidas | |
BRPI0515483A (pt) | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase | |
PE20220761A1 (es) | Inhibidores de dihidroorotato deshidrogenasa | |
PE20120321A1 (es) | Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa | |
NZ600840A (en) | Indole compound and pharmaceutical use thereof | |
NO20064599L (no) | Substituerte morfolin- og tiomorfolinderivater | |
AR054411A1 (es) | Combinacion farmaceutica que comprende un compuesto olefinico de 8- azoniabiciclo [ 3.2.1] octano y uno o mas ingredientes terapeuticos distintos, composicion farmaceutica que la comprende y uso de dichos componentes para prepararla | |
PE20071092A1 (es) | Composicion farmaceutica que comprende un antagonista de cb1 y un agente antisicotico | |
NO20085271L (no) | Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni | |
AR068988A1 (es) | Composiciones farmaceuticas | |
WO2007025880A3 (en) | Pyrazolone derivatives as 11-beta hsd1 inhibitors | |
GT200800058A (es) | Diarilurea para el tratamiento de hipertensión pulmonar | |
AR038213A1 (es) | Esteres hidroxamato del acido n-(4-fenil sustituido)-antranilico | |
AR066077A1 (es) | Tiadiazoliloxifenilamidinas y su uso como fungicidas | |
PA8628901A1 (es) | Derivados de 4-alquil-y 4-alcanoil-piperidina sustituidos y su uso como antagonistas de neuroquininas | |
CL2011002461A1 (es) | Compuestos derivados de tipo amida de compuestos [3,2-c] pirazol con actividad glucocorticoide utiles en condiciones inflamatorias y alergicas como asma, epoc o rinitis alergica. | |
EA201100368A1 (ru) | Амидные соединения, полезные в терапии | |
NZ620074A (en) | 2,5-disubstituted arylsulfonamide ccr3 antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |